The Gal/GalNAc lectin (Gal-lectin) of Entamoeba histolytica is a surface molecule involved in parasite adherence to host cells and is the most promising subunit vaccine candidate against amoebiasis. As macrophages are the major effector cells in host defense against amoebas, we studied the molecular mechanisms by which Gal-lectin activates macrophage. Microarray analysis showed that Gal-lectin up-regulated mRNAs of several cytokines and receptor genes involved in proinflammatory responses. The mechanism whereby the Gal-lectin regulates Tolllike receptor 2 (TLR-2) expression in macrophages was studied. Native Gal-lectin increased TLR-2 mRNA expression in a dose-and time-dependent fashion; peak response occurred with 1 µg/ml after 2 h stimulation. By immunoflourescence, enhanced surface expression of TLR-2 was observed after 12 h. With the use of nonoverlapping anti-Gal-lectin monoclonal antibodies that map to the carbohydrate recognition domain, amino acid 596-1082 was identified as the TLR-2 stimulating region. The Gal-lectin increased TLR-2 gene transcription, and the half-life of the mRNA transcripts was 1.4 h. Inhibition of nuclear factor (NF)-κB suppressed TLR-2 mRNA induction by the Gal-lectin. Moreover, cells pretreated with an inhibitor of p38 kinase (SB 208530) inhibited Gal-lectin induced TLR-2 mRNA expression by 40%. We conclude that the Gal-lectin activates NF-κB and MAP kinase-signaling pathways in macrophages culminating in the induction of several genes including TLR-2 and hypothesize that this could have a significant impact on macrophage activation and contribute to amoebic pathogenesis.
efficacy ranging from 67 to 83% was reported using recombinant CRR of the heavy subunit (3). Th1-type of immune response characterized by cell-mediated immunity (CMI) has been shown to confer resistance against amoebiasis. We have previously shown that the Gal-lectin induces the expression of several proinflammatory molecules including nitric oxide, tumor necrosis factor (TNF)-α, and interleukin (IL)-12 from macrophages (4) (5) (6) . However, the signal transduction pathways initiated by the Gal-lectin leading to priming or activation of macrophages are not known.
Toll-like receptors (TLRs) are recently discovered pattern recognition receptors (PRRs) that recognize conserved molecular patterns on pathogens. Activation of TLRs on the surface of antigen presenting cells (APCs) induces the expression of costimulatory molecules and secretion of proinflammatory cytokines via activation of the transcription factor nuclear factor (NF)-κB (7) . Recently, a number of reports have suggested a potential role for TLRs in intestinal inflammation (8) (9) (10) .
With the notable exception of lipopolysaccharide (LPS), very few studies have examined the intracellular mechanisms initiated by pathogens or their products that activate host immune cells. Of the multitude of signaling cascades, NF-κB and MAP kinase pathways play a central role in cellular response to diverse stimuli. The transcription factor NF-κB regulates several proinflammatory molecules such as IL-12 and TNF-α (11) . Recently, it has also been shown to regulate TLR-2 gene expression (12) . MAP kinases play a critical role in regulating the expression of several cytokines through activation of transcription factors (13) (14) (15) . Extending our molecular characterization studies to decipher the mechanisms of macrophage activation by the Gal-lectin, we studied the regulation of TLRs by the Gal-lectin. Using specific inhibitors, we determined the role of the downstream signaling mediator NF-κB and upstream signaling intermediates such as MAP kinases in Gal-lectin induced TLR-2 mRNA expression.
Herein, we report that TLR-2 expression in response to the Gal-lectin is dependent on NF-κB and p38 MAP kinase in murine macrophages. By monoclonal antibody inhibition studies, we identified that the region between aa 596-1082 of the CRR mediates this response. This is the first report of a parasite molecule up-regulating Toll expression and also implicating MAP kinase in TLR-2 gene regulation. We hypothesize that enhanced expression of TLR-2 could have a profound impact on macrophage activation, skewing the immune response to protective Th1 type. Our study supports the current contention that in the design of an ideal subunit Gal-lectin based vaccine, the CRD regions should be included to optimize Th1 responses. Furthermore, Gal-lectin induced up-regulation of TLR expression in macrophages or other immune cells could play a role in amoebic pathogenesis.
METHODS
Cultivation of E. histolytica and preparation of secretory components, soluble amoebic proteins, and purified Gal-lectin E. histolytica (strain HM1-IMSS) was cultivated in our laboratory as described previously (16) . E. histolytica secretory components (EhSC) were prepared by collecting secretory/excretory components of live amoebas incubated in Hanks' balanced salt solution (2×10 7 /ml) in the absence of serum at 37°C for 2 h. Viability of amoebas after 2 h was 95% as determined by trypan blue exclusion assay. Soluble amoebic proteins (SAP) were prepared from trophozoites in mid log growth phase (3 days) by freeze-thaw lysis. Lysed trophozoites were centrifuged at 15,000 g at 4°C for 10 min, and supernatants were collected. Protein concentration in the EhSC and SAP was quantified by the method of Bradford (17) using bovine serum albumin as standard. The Gal-lectin was purified by mAb affinity chomatography as described previously (18) . Endotoxin contamination was undetectable by the E-Toxate assay (sensitive to 0.05-0.5 endotoxin unit/ml: Sigma) in EhSC at 10 µg/ml, SAP at 50 µg/ml, and Gal-lectin at 1 µg/ml.
Preparation of polyclonal Ab and mAb against the Gal-lectin
Preimmune serum and rabbit polyclonal anti Gal-lectin serum were prepared as described previously (30) . The production of murine anti-Gal-lectin mAbs has been described previously (19) . The epitopes recognized by mAb 1G7 (IgG2b), 7F4 (IgG2b), H85 (IgG2b), 3F4 (IgG1), and 8C12 (IgG1) were mapped to the CRR of the Gal-lectin (Fig. 6 ) using a series of successive deletion peptides of the 170 kDa Gal-lectin subunit (20) . Monoclonal antibodies 3F4 and 7F4 act as internal isotype-matched controls.
Cell culture and reagents
The murine macrophage cell line RAW 264.7 was obtained from American Type Culture Collection (Rockville, MD) and maintained in RPMI (Life Technologies Inc.) medium with 10% FCS. The cells were grown in tissue culture flasks at 37°C in 5% CO 2 and passaged regularly to maintain logarithmic growth. PD98059, a specific inhibitor of ERK kinase, and SB208530, a specific inhibitor of p38 kinase, were purchased from Calbiochem (San Diego, CA). LPS from Escherichia coli serotype 0111:B4, cycloheximide, PDTC, and anti Goat IgG FITC conjugate (F7367) are from Sigma (St. Louis, MO). Wortmannin and herbimycin-A are from Alexis Biochemicals (Qbiogene, Carlsbad, CA). All other antibodies, NF-κB consensus, and mutant oligonucleotides are from Santa Cruz Biotechnology (Santa Cruz, CA). NE-PER nuclear and cytoplasmic extraction kit was from Pierce (Rockford, IL). Poly (dI-dC) was from Amesham Pharmacia Biotech. All primers and actinomycin-D are from Invitrogen.
Northern blot analysis
Total cellular RNAs were extracted using TRIZOL reagent (Life Technologies, Rockville, MD) according to the instructions of the manufacturer. Aliquots (10 µg) of the total RNAs were fractionated in a 1% agarose gel containing 10 mM sodium phosphate buffer and transferred to a nylon membrane. After ultraviolet cross-linking, the membranes were prehybridized for 3 h at 42°C in hybridization solution (5x SSPE, 50x Denhardt's solution, 50% formamide, 0.25mg/ml of salmon sperm DNA, and 0.1% SDS) followed by incubation with 32 P-labeled probe in the same solution for 14 h. The membranes were washed in 2x SSC for 15 min twice at room temperature and in 0.1% SSC +0.1% SDS for 15 min twice at 50°C (0.5% SSC+0.1% SDS at 60°C twice for actin) and were exposed to Kodak XAR-5 film with an intensifying screen for 12-18 h at -70°C. Blots were scanned and densitometric results analyzed with the UN-SCAN IT Gel program. The mTLR-2 DNA probe was prepared by amplifying 2300 bp coding region by RT-PCR and cloning into TA vector. Actin probe consisted of a 1.25 kb PstI fragment of pBA-1.
Western blot analysis
Nuclear or cytoplasmic extracts were collected from 2 x 10 7 cells using the Pierce NE-PER kit as per the instructions of the manufacturer. Protein concentrations were estimated by micro BCA method (Pierce). Equal amounts of the samples were then separated in 12% SDS-polyacrylamide gels and transferred onto nitrocellulose membrane (Bio-Rad). The membranes were blocked in 3.5% skim milk-TBS-T (20 nm Tris-HCl, pH 7.5, 500 mM NaCl, 0.1% Tween-20) at 4°C overnight, incubated with primary antibodies in skim milk-TBS-T at 4°C overnight, washed three times with TBS-T, and incubated with HRP-conjugated anti mouse or goat Ig in skim milk-TBST overnight at 4°C. After three washes each in TBS-3T and TBS-T, the blot was developed with the enhanced chemiluminescence system (Amersham Pharmacia Biotech, Piscataway, NJ) according to the instructions of the manufacturer.
Nuclear run-on assay TLR-2 gene transcription was detected in a PCR-based nuclear run-on assay (5). After 2 h of stimulation, macrophages (2×10 7 /sample) were washed in PBS and resuspended in lysis buffer (320 mM sucrose, 5 mM MgCl 2 , 10 mM Tris-HCl, 1% Triton X-100, pH 7.5), incubated on ice for 10 min, and centrifuged at 1300 g for 15 min at 4°C. The nuclear pellets were washed once in lysis buffer, and the nuclei were divided into two aliquots, each resuspended in 100 µl of storage buffer (50mM Tris-HCl, pH 8.0, 40% glycerol, 0.1 mM EDTA, 5 mM MgCl 2 , and 1 mM DTT) and frozen in liquid nitrogen until use. Elongation of the nascent RNA in vitro was done by adding 100 µl of transcription buffer (20 mM Tris-HCl, pH 8.0, 300 mM KCl, 10 mM MgCl 2 , 200 mM sucrose, 48 µM EDTA, and 1 mM DTT) with or without ribonucleotide phosphates (1 mM each of rATP, rCTP, rGTP, and rUTP) to 100 µl of nuclei and incubating at 30°C for 30 min. The reactions were stopped by adding 1 ml Trizol, and RNA was extracted for RT-PCR analysis. A difference between samples incubated with and without rNTP is indicative of active transcription.
Electrophoretic mobility shift assay
All buffers, including those in the NE-PER kit, were added with a mixture of protease inhibitors (1 µg/ml each of aprotinin, leupeptin, pepstatin, 0.5 mM PMSF, and 1 mM EDTA). Doublestranded NF-κB consensus oligonucleotide was labeled with [γ 32 P]-ATP, using T4 polynucleotide kinase. Unlabeled nucleotides were removed using Sephadex G-25 columns. The binding reaction consist of 20 µl total volume of 0.5 ng of DNA probe, 5 µg of nuclear extract, 1 µg of poly (dI-dC) in the binding buffer (12 mM HEPES, 60 mM KCl, 4 mM MgCl 2 , 1 mM EDTA, 1 mM of DTT, and 12% glycerol; pH 8.0), and incubation for 30 min at room temperature. For competition assay, nuclear extracts were incubated with 50-to 100-fold excess of unlabeled probe before the addition of labeled probe. For supershift assay, 2 µl of anti p65 NF-κB were incubated with nuclear extract for 2 h before binding reaction. DNA-protein complexes were resolved by electrophoresis on 6% polyacrylamide gels at 4°C in TBE buffer (90 mM Tris-borate, 2 mM EDTA). Gels were subsequently dried and autoradiographed with intensifying screens at -70°C.
Immunofluorescent assay
Macrophages were grown on coverslips and stimulated with Gal-lectin or LPS for 12 h. Cells were washed with 1x PBS, fixed in 4% paraformaldehyde at room temperature for 1 h, washed again, and permeabilized with cold absolute methanol for 20 min at -20°C. The cells were incubated with primary antibody to TLR-2 or control goat IgG (in PBS) for 1 h at room temperature and washed, and FITC-conjugated secondary antibody (in PBS-Evans's blue) was added and incubated at room temperature for 1 h in dark. Finally, the coverslips were mounted onto microscopic slides using Vectashield as a quenching solution and were examined under fluorescent microscope.
Microarray study
GE Array Q series mouse NF-κB signaling pathway specific-gene array membrane (MM-016; SuperArray Biosciences Corp., Frederick, MD) was used to study the differential expression of genes involved in NF-κB mediated signal transduction. RNA was extracted using TriZol reagent (Invitrogen) from RAW 264.7 cells stimulated with lectin or with medium alone. Probe labeling and hybridization to the membranes were done as per the instructions of the manufacturer. Membranes were exposed to X-ray film, and data acquisition was done using the ScanAlyze software. The numerical data generated by ScanAlyze were analyzed using another software, GEArray Analyzer. Both of these software programs are free and can be downloaded from the website, www.superarray.com. Initially, all raw signal intensities were corrected for background by subtracting the signal intensity of a negative control, PUC18. This was followed by normalization of all signal intensities to that of the housekeeping gene GAPDH. These corrected, normalized signals were then used to estimate the relative abundance of particular transcripts.
RESULTS

Gal-lectin induces proinflammatory response from macrophages
From our previous observations on Gal-lectin induction of TNF-α and IL-12 from macrophages, we hypothesized that this molecule might be stimulating an NF-κB mediated proinflammatory pathway. Accordingly, microarray studies were done using NF-κB specific gene array with control and Gal-lectin stimulated macrophages (Fig. 1 ). As shown in Table 1 , the Gal-lectin upregulated several cytokines and molecules involved in inflammation and down-regulated others. Of particular interest to the present objective is the up-regulation of TLR-2. Thus, we further probed the mechanism of regulation of TLR-2 by Gal-lectin with a view to decipher the signaling pathways activated by the Gal-lectin.
Gal-lectin stimulates TLR-2 mRNA and protein expression in macrophages
To determine if TLR-2 mRNA expression is altered in response to amoebic components in general, cells were stimulated with EhSC, SAP, and purified Gal-lectin for 2 h, and relative mRNA levels were detected by Northern blot analysis. As shown in Fig. 2 , EhSC and SAP, which contain Gal-lectin and other proteins, stimulated TLR-2 mRNA expression moderately while purified Gal-lectin induced significant expression (3-to 4-fold) of TLR-2 mRNA indicating the relative potential of this molecule. Based on this and microarray data, subsequent studies were done on TLR-2 regulation by the purified Gal-lectin. As shown in Fig. 3A , Gallectin stimulated TLR-2 mRNA expression in a dose-dependent fashion. Significant expression was induced with as little as 250 ng/ml of Gal-lectin, and peak response was observed with 1 µg/ml. In a detailed time course experiment with a suboptimum dose of 500 ng/ml of Gal-lectin, TLR-2 mRNA expression was induced by 1 h, peaked at 2 h, and returned to basal levels by 12 h (Fig. 3B) . The surface expression of TLR-2 protein was significantly increased when stimulated with 1 µg/ml of lectin for 12 h (Fig. 4) and was comparable to that stimulated with LPS (data not shown), demonstrating the potency of the Gal-lectin in stimulating TLR-2 mRNA as well as protein expression in macrophages.
Polyclonal antiserum and mAbs against the CRR of Gal-lectin inhibit TLR-2 mRNA expression
To address the specificity for the Gal-lectin, polyclonal rabbit immune serum (1:1000) raised against the native Gal-lectin was used to inhibit TLR-2 induction. As shown in Fig. 5 , anti Gallectin serum inhibited Gal-lectin induced TLR-2 expression by 90% while LPS-mediated response remained unaffected. Preimmune serum at 1:1000 did not affect TLR-2 expression. To identify the specific region of the Gal-lectin that stimulates TLR-2 mRNA expression, we examined the inhibitory effects of a panel of monoclonal antibodies that map to nonoverlapping epitopes on the CRR of the Gal-lectin (Fig. 6 ). Three mAbs, 1G7 (aa 596-818), 8C12 (aa 895-998), and H85 (aa 1033-1082), markedly inhibited TLR-2 mRNA expression in response to Gallectin, whereas mAb 3F4 (aa 895-998) and 7F4 (aa 1082-1138) did not (Fig. 7) . The latter mAbs also acted as internal isotype controls. Thus, aa 596-1082 of the CRR is responsible for stimulating TLR-2 mRNA expression in macrophages.
Regulation of TLR-2 mRNA expression in response to Gal-lectin
Previous studies have shown that the proinflammatory cytokines TNF-α and IL-1β can upregulate TLR-2 mRNA expression in murine macrophages (21) . As Gal-lectin can also stimulate proinflammatory cytokines from macrophages, we determined if TLR-2 induction by Gal-lectin occurs directly or via autocrine stimulation with these cytokines. As shown in Fig. 8 , no change in TLR-2 mRNA expression was observed when macrophages are stimulated with Gal-lectin in the presence of neutralizing antibodies against TNF-α and IL-1β, confirming that TLR-2 mRNA expression is independent of these cytokines. Moreover, TNF-α and IL-1β stimulated TLR-2 mRNA expression similar to the Gal-lectin, and this induction was completely inhibited by their respective neutralizing antibodies. To determine if de novo protein synthesis is required for TLR-2 mRNA expression, cells were pretreated with different concentrations of cycloheximide for 30 min and then stimulated with Gal-lectin for 2 h. Cycloheximide treatment markedly increased TLR-2 mRNA expression in both control and stimulated cells (Fig. 9) , indicating that newly synthesized proteins negatively regulate TLR-2 mRNA expression. Actinomycin-D treatment followed by RNA chase experiment was done to examine the stability of the TLR-2 mRNA transcript induced by Gal-lectin in comparison to that of LPS. The t 1/2 for TLR-2 mRNA transcripts induced by the Gal-lectin was calculated to be 1.4 h while that induced by LPS was 2.5 h (Fig. 10) . These results show that TLR-2 mRNA induced by lectin is stable and undergoes slow posttranscriptional degradation similar to that of LPS. The molecular regulation of TLR-2 gene expression was determined by a PCR based nuclear run-on assay. As shown in Fig. 11, a threefold increase of TLR-2 gene transcription was observed in cells stimulated with Gal-lectin, similar to that of the positive control LPS.
NF-κB is involved in Gal-lectin induced TLR-2 mRNA expression
NF-κB has been shown to regulate TLR-2 gene transcription in murine macrophages (12) . Hence, its role in Gal-lectin induced TLR-2 gene transcription was determined using two NF-κB inhibitors, pyrollidine dithiocarbamate (PDTC) and SN50 peptide. As shown in Fig. 12A , PDTC inhibited Gal-lectin induced TLR-2 expression by 64% at 10 µM concentration and completely suppressed TLR-2 expression at 25 µM. Moreover, the specific NF-κB inhibitor SN50 inhibited TLR-2 mRNA induction by 80% (Fig. 12B) , confirming a role for this transcription factor in Gal-lectin signaling. In support of this, we observed nuclear translocation of the two subunits of NF-κB, p65 and p50, as early as 30 min after Gal-lectin stimulation (Fig. 12C) . Furthermore, EMSA was done to check the DNA binding activity of NF-κB that was activated by the Gallectin. As shown in Fig. 12D , Gal-lectin treatment significantly increased the DNA binding activity of NF-κB. Specificity was determined by pretreatment of the nuclear extracts with 50-and 100-fold concentration of cold probe and by a mutant NF-κB consensus sequence. As expected, pretreatment of nuclear extracts with cold probe inhibited DNA binding by the labeled probe in a dose-dependent fashion, whereas pretreatment with mutant probe did not inhibit subsequent binding by the labeled probe. The p65 subunit of NF-κB has been implicated in the transcativating function of this transcription factor (11) . Thus, to determine if this subunit is activated by the Gal-lectin, supershift assay was done using anti p65 antibody. Figure 12E shows a clear supershifted band, validating its role in Gal-lectin signaling.
Role of MAP kinases in Gal-lectin induced TLR-2 mRNA expression
MAP kinases play a key role in cellular responses to diverse stimuli by acting as signaling intermediates in the expression of cytokines (13) (14) (15) . Accordingly, we tested if the Gal-lectin can activate the MAP kinase pathways. By Western blot studies employing antibodies against phosphorylated forms of the three important MAP kinases, ERK, JNK, and p38, we observed that the Gal-lectin activates p38 kinase (Fig. 13A) but not ERK or JNK (data not shown). Specific inhibitors of the MAP kinase pathways were then used to check their role in Gal-lectin induced TLR-2 mRNA expression. As shown in Fig. 13B , pretreatment of cells with SB203580, a specific inhibitor of the p38 kinase pathway, significantly inhibited (by 40%) TLR-2 mRNA induction by Gal-lectin, whereas the ERK inhibitor had no effect. To understand further the upstream signaling events in Gal-lectin signaling, we studied the effects of two inhibitors wortmannin, a PI3 kinase inhibitor, and herbimycin-A, a specific PTK inhibitor on Gal-lectin induced TLR-2 mRNA expression. Neither of these inhibitors had any significant effect on TLR-2 mRNA expression (Fig. 14) , suggesting that PI3 kinase and tyrosine kinases do not play a role in Gal-lectin mediated TLR-2 expression. DISCUSSION DNA microarray technology is increasingly becoming a powerful tool that allows a global view of gene profiling in a rapid and efficient fashion (22) , and several researchers are reporting microarray analysis of mRNA levels from macrophages in response to variety of pathogens (23, 24) . Hence, we initially exploited this technique to have simultaneous analysis of 96 genes involved in the NF-κB signaling pathway. The observed gene profile, overall, supports our previous observations of proinflammatory cytokine induction and suggests the involvement of the important transcription factor NF-κB in Gal-lectin signaling. As we are interested in the regulation of Toll receptors and deciphering the signaling events involved in this activation, we focused our study on regulation of TLR-2 induction by the Gal-lectin. Of the 10 TLRs identified to date in mammals, TLR-2 appears to be the most promiscuous one that can be activated by a variety of stimuli. In this study, we show that the Gal-lectin induces robust TLR-2 expression in murine macrophages. To our knowledge, this is the first purified molecule isolated from a parasite that induces Toll receptor expression in macrophages. The others include LPS from Gram-negative bacteria (21) , H. influenzae (25) , and M. avium (26) . In addition, several parasitic components have been shown to signal via TLR-2 and activate the Toll pathway. These include GPI anchors and protein Tc52 from T. cruzi (27, 28) and schistosomal lyso-phosphatidyl serine (29) . Although our study shows that Gal-lectin can stimulate TLR-2 expression, it is premature to hypothesize that it is a ligand for TLR-2.
Using a panel of monoclonal antibodies, we identified the region of Gal-lectin that stimulates TLR-2 mRNA expression and protein production. This is of paramount importance in the design of a subunit vaccine. The same region of the Gal-lectin stimulates TNF-α and IL-12 production by macrophages. It is interesting to note that IFN-γ priming was not necessary for the Gal-lectin induced TLR-2 mRNA or protein expression by murine macrophages. Thus, even unprimed APCs exposed to Gal-lectin can express high levels of this Toll receptor, which can potentially contribute to skewing the immune response to protective Th1 type. In addition, other workers have shown that all the functional properties of Gal-lectin such as parasite adherence, cytotoxicity, and complement resistance are mediated by the CRR, a part of the large extracellular domain (2, 30) . In this context, it would be of interest to explore the structural properties that confer such diverse functionalities to this molecule and to the CRR in particular.
NF-κB encompasses a very important family of transcription factors and is critical for the inducible expression of several genes involved diverse cellular responses (11) . The promoter region of murine TLR-2 contains the following consensus binding sequences: two NF-κB, two CCAAT/enhancer binding proteins, one cAMP response element-binding protein, and one STAT (12) . Hence, it is not surprising that NF-κB plays a central role in TLR-2 gene expression. In fact, LPS and M. avium have been shown to regulate TLR-2 mRNA via NF-κB (12, 26) . We also observed that NF-κB plays a critical role in Gal-lectin induced TLR-2 expression. This is consistent with the observation that no new protein synthesis is required for TLR-2 induction by the Gal-lectin, as initial NF-κB activation does not require de novo protein synthesis (31) . Although both Gal-lectin and LPS regulate TLR-2 in an NF-κB dependent manner, there are clear differences in the mechanisms used by these diverse molecules. Although MAP kinases do not play a role in LPS-mediated TLR-2 regulation, p38 kinase was a significant intermediate in Gal-lectin mediated TLR-2 induction. Also, LPS induced a much more robust DNA binding by NF-κB than Gal-lectin at 30 min (data not shown). These observations together with a clear difference in the stability of TLR-2 mRNA suggest that LPS induces a sustained expression of TLR-2, probably through activation of other transcription factors in addition to NF-κB, whereas Gal-lectin induces a less stable expression of TLR-2, which appears to be dependent mainly on NF-κB. This is supported by the fact that NF-κB was not absolutely necessary for LPS-induced TLR-2 gene expression (12) , whereas inhibition of this single transcription factor by SN50 peptide resulted in 80% inhibition of TLR-2 mRNA expression induced by the Gal-lectin. However, promoter analysis studies are warranted to assess the full spectrum of transcription factors involved in Gal-lectin induced TLR-2 gene expression and to identify the putative responsive elements in the gene promoter region. These differences are also reflected in the kinetics of protein expression where a significant expression with Gal-lectin was observed only at 12 h while LPS stimulation resulted in a relatively rapid induction by 6 h (data not shown). Although we showed that both Gal-lectin and LPS induce TLR-2 gene transcription, differential posttranscriptional regulation of TLR-2 mRNA might be responsible for these quantitative and kinetic differences.
The family of MAP kinases includes the extracellular signal-regulated kinase (ERK), c-Jun Nterminal kinase (JNK), and p38 kinase. p38 MAP kinase is an important mediator of stressinduced gene expression (32) , and it appears to differentially regulate TLR-2 mRNA expression in different cell types in response to different stimuli. p38 kinase and ERK pathways have been shown to positively regulate TLR-2 mRNA expression in response to PMA in T-lymphocytes (33), while nontypeable Hemophilus influenzae and glucocorticoids were reported to enhance TLR-2 expression in human epithelial cells via a negative cross-talk with p38 kinase (25) . We showed that the p38 kinase pathway is a significant mediator of TLR-2 induction by the Gallectin. Several lines of experimental evidence support this contention. First, Gal-lectin induced a marked phophorylation of p38 kinase as early as 30 min. Second, pretreatment of cells with SB203580, a specific inhibitor of p38 kinase, blocked Gal-lectin induced TLR-2 mRNA expression by 40%. In contrast, inhibiting the ERK pathway resulted in a slight increase in TLR-2 mRNA expression, confirming an earlier report of negative regulation by ERK (21) in response to LPS stimulation. However, the clear discrepancy in signal transduction pathways activated by Gal-lectin and LPS is that Gal-lectin does not activate ERK or JNK, whereas LPS potently induces both. As well, LPS mediated TLR-2 mRNA induction was not significantly inhibited even at a 50 µM concentration of SB208530 (21) . Although the exact mechanism for this differential activation is not known, modulation of different membrane receptors may be involved.
MAP kinases are one of the downstream targets for protein tyrosine kinases (PTKs), and inhibition of PTK and PI3 kinase activities has been shown to modulate transcription factor activation and gene induction (11, (34) (35) (36) . Both have been implicated in induction of proinflammatory molecules such as iNOS and TNF-α in response to LPS and IFN-γ (37, 38). However, specific inhibitors at concentrations shown to inhibit respective target kinases fail to influence the TLR-2 mRNA expression by Gal-lectin. PKC is one of the prominent downstream target of PI3-kinase (39), and we previously observed that E. histolytica activated and translocated PKC to the membrane fraction in murine macrophages (40) . Also, previous reports have shown that these kinases are involved in transcription factor activation and gene induction (40, 41) . However, we failed to associate these kinases with TLR-2 expression, indicating that Gal-lectin induced NF-κB and p38 are independent of PI3 kinase and tyrsosine kinases.
Although this study clearly helps in developing an ideal subunit vaccine against this important pathogen, its contribution to furthering our understanding of amoebic pathogenesis, and intestinal inflammation in general, cannot be ignored. Our observation of up-regulation of TLR-2, via NF-κB, by the Gal-lectin is of paramount importance in this context. The contribution of NF-κB, particularly the p65 subunit, to intestinal inflammation has been well documented (42) (43) (44) .
Up-regulation of TLR-2 could definitely be one of the diverse consequences of NF-κB activation. Indeed, several reports revealed an increased expression of TLRs in both epithelial cells and lamina propria macrophages during inflammatory conditions (8) (9) (10) 45) . Recently, TLR-2 was shown to contribute to liver injury by Salmonella infection via Fas ligand expression on NKT cells in mice (46) . Based on this work and other studies, a working model for the role of TLR-2 in amoebic pathogenesis can be hypothesized (Fig. 15) , wherein E. histolytica through Gal-lectin enhances the surface expression of TLR-2 in lamina propria mononuclear cell (LPMNCs), which renders these cells more responsive to diverse ligands of gut pathogens or even commensals, which gain access to these underlying cells though the leaky gut. During the course of E. histolytica infection, there is ample opportunity for epithelial cells and LPMNCs to be exposed to Gal-lectin either through direct contact with the trophozoites or through exposure to the secreted products and/or lysates of dead amoebas. The consequent activation of TLRs in intestinal epithelium results in further influx of inflammatory cells and development of colitis, thus perpetuating an uncontrollable intestinal inflammation. Thus, this study further supports the current contention of regulating the TLR function as an attractive therapeutic target for controlling intestinal inflammation during infections with gut pathogens. It should be emphasized that this model proposes a role for TLR-2 in the exacerbation of the mucosal inflammation rather than in initiating the pathogenesis. Future proteomic studies might identify novel parasitic molecules such as lipoproteins or lipophosphoglycans as potential ligands for Toll receptors, which might directly implicate the innate pattern recognition receptors in amebic colitis. Macrophages were treated with either medium alone or 500 ng/ml of Gal-lectin for 2 h, and differential gene expression was studied as described. The experiment was done twice, and genes increased at least by 3-fold (up-regulated) or decreased by less than half (down-regulated) in Gal-lectin treated cells compared to that of control cells in both the experiments are shown. Purified Gal-lectin (500 ng/ml) or LPS (100 ng/ml) was treated with either medium, preimmune rabbit serum (1:1000), or polyclonal anti-lectin serum (1:1000) for 2 h at 4°C before incubation with macrophages for 2 h at 37°C. Results of scanning densitometric analysis of Northern blot are presented as histogram with identical lanes for Northern blot and histograms. Value in parenthesis are percentage of inhibition relative to homologous controls. Gal-lectin (500 ng/ml) or medium only in the presence or absence of neutralizing antibodies against mouse TNF-α (2 µg/ml) or IL-1β (10 µg/ml) for 2 h, and total RNA was collected for subsequent Northern blot analysis. Under the same conditions, recombinant mouse TNF-α (10 ng/ml) and IL-1β (10 ng/ml) were used as specific controls. Results are from 3 separate experiments. . NF-κB is involved in Gal-lectin signaling. A). Cells were pretreated with NF-κB inhibitor pyrollidine dithio carbomate (PDTC) at different concentrations or medium alone for 30 min before stimulating with lectin (500 ng/ml) for 2 h and Northern analysis. Values in parenthesis are percentage of inhibition relative to that observed with lectin. B) Cells were pretreated with 100 µg/ml of either control peptide (CP) or SN50 peptide (SN50) for 1 h before stimulation with 500 ng/ml of Gal-lectin for 2 h. Figure in parenthesis is percentage of inhibition relative to that observed with control peptide. C) Western blots showing the nuclear translocation of NF-κB subunits by the Gal-lectin. Cells were stimulated with 500 ng/ml each of lectin or LPS for 30 min and 2 h, and nuclear extracts were collected as described. Thirty mirograms of protein were fractionated by SDS-PAGE and probed with antibodies against the two NF-κB subunits p65 and p50. D) NF-κB activation by the Gal-lectin. Macrophages were stimulated with Gal-lectin (500 ng/ml) for 30 min. Nuclear extracts from stimulated and unstimulated cells were prepared as described in Methods and then assayed for DNA binding activity by EMSA. Arrows indicate positions of DNA complexes. E) Supershift with anti p65 antibody. To check the specificity and identify the subunits induced by Gal-lectin, the nuclear extracts were preincubated anti p65 antibody for 2 h before EMSA. Supershifted band (arrow) with p65 is shown. were stimulated with Gal-lectin (1 µg/ml) or LPS (1 µg/ml) for 30 min, cytoplasmic extracts were prepared using NE-PER kit, and 100 µg of protein per lane were fractionated by SDS-PAGE. Membranes were probed with antibodies that specifically recognize the phosphorylated form of p38. To check equal loading, membranes were subsequently stripped and reprobed with antibody that recognizes total p38. B) p38 kinase is involved in Gal-lectin-induced TLR-2 mRNA expression. Cells were treated with indicated concentrations of specific MAP kinase inhibitors for 30 min before being stimulated with Gal-lectin for 2 h. Value in parenthesis is percentage of inhibition relative to that induced by the Gal-lectin. Results are representative of 3 separate experiments. propria mononuclear cells (LPMNC) by Gal-lectin of E. histolytica via NF-κB and p38 pathways will amplify the Toll signaling activated by diverse ligands in gut. The resulting amplified proinflammatory cytokine response from leukocytes in turn can up-regulate Toll receptor expression in epithelial cells (47) . Consequently, epithelial cells that are hitherto unresponsive/hyporesponsive to gut antigens begin responding to diverse Toll ligands. The resulting production of chemokines and cytokines while helping to signal the adaptive response also contributes to inflammatory reaction by recruiting phagocytes to the site of tissue damage.
